According to the research report titled ‘Global Dry Eye Disease (DED) Market - Analysis By Disease (Aqueous, Evaporative, Others), Treatment, End User, Distribution Channel, By Region, By Country (2021 Edition): Market Insights, Covid -19 Impact, Competition and Forecast (2021-2026)’, available with Market Study Report, global dry eye disease (DED) market was worth USD 5378.59 million in 2020 and is anticipated to showcase lucrative growth trends between 2021 and 2026.
 

Increased life expectancy, rising elderly population, growing pool of working population with longer screen timings along with lifestyle changes are major factors driving the growth of global dry eye disease market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3542234/
 

Based on disease, the industry is segmented into aqueous, and evaporative including others. As cited in the report, evaporative dry eye disease market segment is expected to hold a substantial share in the forthcoming years, due to prevalence of this disorder with associated meibomian gland dysfunction.
 

On the basis of end user spectrum, the industry space is fragmented into home health care, hospitals, and clinics. Among these, hospitals segment, followed by clinics, is anticipated to acquire a considerable market share by the year 2026, owing to increasing number of people suffering from eye disorders, along with manufactures spending profoundly to create awareness among people and expand their manufacturing capacity.
 

Speaking of treatment type, worldwide dry eye disease marketplace is divided into eye drops, and anti-inflammatory drugs among others. Moving on to distribution channel, the market is categorized into retailers, hospital pharmacies, online, and others.
 

As per regional framework, North America, followed by Europe and Asia Pacific regions, is expected to impel global dry eye disease industry growth graph over the forecast duration, owing to factors such as presence of key manufactures in the region, with companies boosting their production capacity.  
 

Key players in worldwide dry eye disease industry include Sentiss Pharma Pvt. Ltd., Novaliq GmbH, Horus Pharma, VISUfarma B.V., Santen Pharmaceutical Co. Ltd., Novartis International AG, Allergan plc, Alcon, Bausch Health Companies Inc., and Johnson & Johnson.